Skip to main content
. 2023 Sep 25;46(2):1775–1788. doi: 10.1007/s11357-023-00941-z

Table 1.

The characteristics of study participants

All participants (n = 560) Males (n = 276, 49.3%) Females (n = 284, 50.7%)
Chronological age (years); mean (SD) 74.5 (4.2) 74.5 (4.2) 74.5 (4.2)
Epigenetic age (years)
  HorvathAge; mean (SD) 70.6 (6.1) 71.0 (6.1) 70.1 (6.0)
  HannumAge; mean (SD) 59.5 (6.1) 60.4 (6.1) 58.6 (6.0)
  PhenoAge; mean (SD) 58.9 (7.7) 59.7 (7.7) 58.1 (7.6)
  GrimAge; mean (SD) 70.1 (5.0) 71.5 (5.1) 68.6 (4.5)
  GrimAge2; mean (SD) 74.1 (5.3) 75.4 (5.5) 72.8 (4.8)
  DunedinPACE; mean (SD) 0.97 (0.11) 0.99 (0.11) 0.95 (0.11)
Epigenetic age acceleration (AA, years)
  HorvathAA; mean (SD) 0.08 (4.96) 0.49 (4.96)  − 0.31 (4.92)
  HannumAA; mean (SD) 0.07 (4.84) 0.79 (5.04)  − 0.64 (4.54)
  PhenoAA; mean (SD) 0.09 (6.37) 0.76 (6.46)  − 0.55 (6.21)
  GrimAA; mean (SD) 0.02 (3.52) 1.35 (3.34)  − 1.27 (3.19)
  Grim2AA; mean (SD) 0.02 (4.04) 1.16 (3.99)  − 1.08 (3.78)
Other measures of biological aging
  Mean brain agea; mean (SD) 72.1 (6.9) 72.1 (7.4) 72.1 (6.4)
  Brain-PADa; mean (SD)  − 1.50 (6.05)  − 1.70 (6.39)  − 1.27 (5.67)
  Deficit accumulation frailty index; mean (SD) 0.10 (0.06) 0.09 (0.06) 0.12 (0.06)
Participants’ characteristics
Years of education; n (%)
   < 12 years 234 (41.8) 111 (40.2) 123 (43.3)
   ≥ 12 years 326 (58.2) 165 (59.8) 161 (56.7)
Living situation; n (%)
  At home alone 159 (28.4) 47 (17.0) 112 (39.4)
  With family or others 401 (71.6) 229 (83.0) 172 (60.6)
Socioeconomic status (SES)b; n (%)
  Very low 48 (8.6) 23 (8.4) 25 (8.8)
  Low 44 (7.9) 19 (6.9) 25 (8.8)
  Middle 85 (15.2) 43 (15.6) 42 (14.8)
  High 121 (21.7) 61 (22.2) 60 (21.1)
  Very high 261 (46.7) 129 (46.9) 132 (46.5)
Smoking; n (%)
  Never 312 (55.7) 129 (46.7) 183 (64.4)
  Former 227 (40.5) 135 (48.9) 92 (32.4)
  Current 21 (3.8) 12 (4.4) 9 (3.2)
Alcohol consumption, n (%)
  Never 80 (14.3) 25 (9.1) 55 (19.4)
  Former 21 (3.8) 12 (4.4) 9 (3.2)
  Current-low riskc 336 (60.0) 158 (57.3) 178 (62.7)
  Current-high riskd 123 (22.0) 81 (29.4) 42 (14.8)
Clinical measures
  Systolic blood pressure (mmHg); mean (SD) 137.8 (16.0) 140.7 (15.3) 134.9 (16.2)
  Diastolic blood pressure (mmHg); mean (SD) 75.8 (10.2) 77.3 (10.1) 74.2 (10.0)
  Grip strength (kg)e; mean (SD) 28.5 (9.9) 35.9 (7.6) 21.3 (5.6)
  Gait speed (m/s); mean (SD) 1.1 (0.2) 1.1 (0.2) 1.0 (0.2)
Self-reported health outcomes
Self-rated health; n (%)
  Excellent 89 (15.9) 43 (15.6) 46 (16.2)
  Very good 279 (49.8) 133 (48.2) 146 (51.4)
  Good 172 (30.7) 90 (32.6) 82 (28.9)
  Fair 19 (3.4) 10 (3.6) 9 (3.2)
  Poor 1 (0.2) 0 (0.0) 1 (0.4)
Health-related quality of life
  Physical component score; mean (SD) 48.5 (8.7) 49.3 (8.1) 47.7 (9.1)
  Mental component score; mean (SD) 55.5 (7.4) 56.1 (6.4) 54.9 (8.2)
Chronic conditions
Hypertension; n (%)
  Yes 381 (68.0) 197 (71.4) 184 (64.8)
  No 179 (32.0) 79 (28.6) 100 (35.2)
Diabetes; n (%)
  Yes 65 (11.6) 43 (15.6) 22 (7.8)
  No 495 (88.4) 233 (84.4) 262 (92.3)
Dyslipidemia; n (%)
  Yes 351 (62.7) 140 (50.7) 211 (74.3)
  No 209 (37.3) 136 (49.3) 73 (25.7)
Obesityf; n (%)
  Yes 151 (27.1) 70 (25.6) 81 (28.6)
  No 406 (72.9) 204 (74.5) 202 (71.4)
Chronic kidney diseaseg; n (%)
  Yes 107 (20.4) 53 (20.4) 54 (20.4)
  No 418 (79.6) 207 (79.6) 211 (79.6)
Depression; n (%)
  Yes 57 (10.2) 26 (9.4) 31 (10.9)
  No 503 (89.8) 250 (90.6) 253 (89.1)

aNumbers of participants, total n = 400, males n = 209, and females n = 191

bSES, total n = 559, males n = 275, and females n = 284

cCurrent-low risk, ≤ 10 standard drinks per week and ≤ 4 standard drinks on any 1 day

dCurrent-high risk, > 10 standard drinks per week or > 4 standard drinks on any 1 day

eGrip strength, total n = 558, males n = 275, and females n = 283

fObesity, total n = 557, males n = 274, and females n = 283

gChronic kidney disease, total n = 525, males n = 260, and females n = 265

HHS Vulnerability Disclosure